Mandate

Vinge advises consortium led by Advent International on acquisition of Hoist Group Holding Intressenter AB (publ)

Vinge together with Weil, Gotshal & Manges LLP is advising a consortium led by Advent International in connection with its acquisition of Hoist Group Holding Intressenter AB (publ) (the ”Hoist Group”).

Hoist Group provides technology solutions to hotels, enabling them to manage coherent end-to-end digital journeys for their guests. Hoist Group optimizes guest services by correlating and analyzing the data that comes from its innovative Property Management & Booking Software, Managed IP Networks, Internet and TV Content as well as from many other digital touchpoints. Headquartered in Stockholm with 20 offices across EMEA, Hoist Group has nearly 500 dedicated staff serving over 8,000 unique hotels.

The sale is subject to standard regulatory approval, among other things, and is expected to be completed in the second half of 2021. In France, the agreement is subject to completion of French works council consultations.

The Vinge team advising Advent International includes partners Daniel Rosvall, Henrik Borna and Anna Edström, counsel Emelie Svensäter Jerntorp and associates Carl Sander and Viktor Lennartsson. Counsel Fredrik Christiansson advises on financing matters

 

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026